Access the invaluable expertise of Safeguard’s Advisory Board.

Comprised of industry leaders in healthcare and technology, Safeguard’s Advisory Board provides our partner companies with active support, strategic guidance and operational know-how to maximize long-term value.

Ron A. Andrews

Ron A. Andrews joined Life Technologies as President of the Genetic, Medical and Applied Sciences effort. Life Technologies is a $4B NASDAQ company and a leading supplier of genomic and proteomic tools to the life sciences market, and was acquired by Thermo Fisher Scientific in 2013. Ron’s main focus is leading the transition the molecular discoveries from the life science research area into molecular diagnostic applications to improve patient care in the era of personalized medicine.

Prior to joining Life Technologies, Ron was the Founder and Chief Executive Officer of Clarient Inc. Clarient was started in late 2004 as a Molecular Pathology Service organization delivering “academic level” molecular testing services to community pathologists and oncologists. Clarient was one of the fastest growing molecular diagnostics companies over its five year lifespan with a 64% CAGR and delivered significant shareholder value through its 2010 sell to GE Healthcare for $587M. From August 2002, Mr. Andrews was Senior Vice President Global Marketing and Commercial Business Development at Pleasanton, Calif.-based Roche Molecular Diagnostics. In that role, he developed and led the strategic execution for all diagnostic commercial operations. This included the oversight of five business sector vice presidents responsible for all aspects of global marketing and business development in the areas of blood screening, virology, women’s health, microbiology and automation/emerging diagnostics. Ron was also responsible for executive direction of all marketing functions, directed the development of the 10-year Strategic Plan for the organization, and completed the reorganization of commercial operations during that period.

From 2000 to 2002, Ron held two senior executive positions with Indianapolis-based Roche Diagnostics Corporation. As Vice President, U.S. Commercial Operations, Molecular Diagnostics, he directed sales, marketing, technical field support, and product development activities and was responsible for U.S. commercial strategy development for the clinical laboratory market. Prior to that, as Vice President, Marketing, U.S. Commercial Operations, he was responsible for planning and directing all aspects of the Roche U.S. Laboratory Systems Commercial Operations Marketing which included the clinical chemistry, immunochemistry, hematology, near patient testing and molecular markets.

From 1995 to 2000, Ron was Vice President of Atlanta-based Immucor, Inc. where he helped lead the transition of the company from a reagent manufacturer to an instrument systems company. Prior to Immucor, he spent almost 10 years in management positions of increasing responsibility at Chicago-based Abbott Diagnostics, culminating in the position of Senior Marketing Manager, Business Unit Operations.

Ron earned a Bachelor’s degree in Biology and Chemistry from Spartanburg, SC-based Wofford College in 1981 and has participated extensively in the executive development programs at both Roche and Abbott Labs. He currently lives with his wife and three children in Coto de Caza, Calif.

John Applegate

John Applegate is the Chief Information Officer for KPMG. He is responsible for the firm’s global IT environment and he has supplied key contributions in the firm’s IT globalization. Over the last 18 years, John’s primary focus has included: Technology Architecture, Global IT Operating Environment, large global projects, and executive sponsorship of the largest IT suppliers.

Prior to joining KPMG, John earned an Economics degree from Texas A&M and then started his own IT consultancy company in Dallas, Texas. Once he joined KPMG, John sold his profitable business and became responsible for the firms Dallas and Chicago IT Consulting Integration practice. John quickly became Consulting Integrations’ lead person for IT organizational issues and, as such, was asked to participate in reviewing the internal firms need to globalize its internal IT functions (early 1998). During this time he made Partner for KPMG Consulting and remained on the KPMG LLP account as an integral part in deploying the firm’s new IT infrastructure. During this time he and his family relocated to Amsterdam, The Netherlands where the company’s international headquarters is located. When the division, now known as BearingPoint, split from KPMG, John chose to remain with KPMG. The last ten years with this leading company have proved to be a valuable experience with international approaches.

David M. Barrett, MD

David M. Barrett, MD is currently a Clinical Professor of Surgery at the Dartmouth-Hitchcock Medical Center.

Previously, David was CEO Emeritus of Lahey Clinic, a nonprofit, multispecialty health care organization based in Burlington, Mass. Before joining Lahey in September 1999, he had a long and distinguished career as a physician, teacher and administrator at Mayo Clinic in Rochester, Minn. He is the former chair of Lahey’s Board of Governors and a trustee of the Lahey Clinic Foundation.

A native of Michigan, David received his bachelor’s degree from Albion College and his medical degree from Wayne State University School of Medicine. From 1970-72, he served as a flight surgeon during the Vietnam War and was Chief of the Aeromedical Service at Cam Rahn Bay Air Base.

Following his military service, David trained at Mayo Clinic as a resident in general surgery and in urology. He became a staff physician at Mayo in 1975 and served as chair of the Department of Urology throughout most of the 1990s. He also served as vice chair of Mayo’s Board of Governors. He was a Trustee of the Mayo Foundation and a member of the Executive Committee.

David is an authority on urologic oncology, urinary incontinence, bladder reconstruction, and genitourinary prostheses. During the course of his career, he has been widely published in academic journals and has received numerousresearch grants and contracts. He holds a patent for an artificial urinary bladder.

Among his many professional affiliations are memberships in the American College of Surgeons and the American Urologic Association. David is also a member of the American College of Healthcare Executives and won the award for the Health Care Executive of the year in June of 2007. He is a past president of the American Board of Urology, and the American Association of Genitourinary Surgeons. He is also Past Chair of the Massachusetts Hospital Association.

Alfred R. Berkeley III

Alfred R. Berkeley III

Alfred R. Berkeley III currently serves as Chairman of Princeton Capital Management, Inc., a registered investment advisor.

Al has over 40 years of experience in the financial industry. He holds a B.A. from the University of Virginia and received his M.B.A. from The Wharton School at the University of Pennsylvania. He served as a Captain in the United States Air Force from 1968 to 1972.

Al joined Alex. Brown & Sons Incorporated in 1972 as a research analyst. He became general partner of Alex. Brown in 1983. From 1985 to 1987, he served as Head of Information Services for the firm. In that capacity, he was responsible for all corporate information services, including the firm’s back office and front office technology. Al then moved on to Alex. Brown’s Merger and Acquisition department, where from 1987 to 1989 he developed the firm’s technology practice. He became managing director and senior banker in the corporate finance department where he financed computer software and electronic commerce companies. After serving as Alex. Brown and Sons’ Chief Information Officer, Al became CEO of a public telecommunications software company.

In 1996, he was named President of NASDAQ. Al retired from NASDAQ in 2003. He is a Director of Realpage, Inc., the World Economic Forum, USA; Noxilizer, Inc.; Security First Corp.; Gentag, Inc.; ViiNet, Inc.and Differential Dynamics, Inc.

Al was a trustee of the Johns Hopkins University and the Nature Conservancy. He served on the President’s National Infrastructure Assurance Council. He was a trustee of the Mathematical Sciences Research Institute and was a member of the Board of Director of WebEx Communication, Inc.; Policy Management Systems Corporation; ACI Worldwide; and several other companies.

Steve Friedman

Steve Friedman advises early-stage companies in the areas of go-to-market strategy, product positioning, business development and executive recruitment.

Steve serves as an Independent Board Director at AppFirst, and serves on the Advisory Boards at Apprenda, Beyond.com, BizEquity, Safeguard Scientifics (NYSE:SFE), Spongecell and WebLinc.

Past Board roles include Mocana and Boxtone (acquired by Good Technology). Past Advisory Boards include FirstBest Systems, Gigaspaces, Rapid Logic (acquired by Wind River) and Collaxa (acquired by Oracle).

Steve served as BEA Systems’ Vice President, Channels for the Americas. In this position, he was instrumental in growing the indirect channels business to over $100M. Steve came to BEA through the acquisition of WebLogic, where he built and co-managed the field sales organization. Steve also held sales, executive and business development positions with leading Enterprise Software firms.

Randy Gaboriault

Randy Gaboriault is the Chief Information Officer for the Christiana Care Health System one of the largest provider systems in the country. He also serves as the Board Chair for the nation’s first health information exchange, the Delaware Health Information Network.

He serves on the Board of Directors and as Treasurer for Tech Impact, a global nonprofit whose mission is to ensure that all nonprofits can use technology to better serve our world. He also serves as an advisor for Siemens Medical Solutions. Prior to Christiana Care, Randy was Senior Vice President, Chief Information and Strategic Development Officer for Teleflex, a global provider of medical devices serving healthcare providers with specialty devices for vascular access, general and regional anesthesia, urology, respiratory care, cardiac care and surgery. During his tenure, Randy held responsibility for logistics, organizational excellence and strategic sourcing.

Distinctions include: Information Week’s “Twenty Great Ideas To Steal,” Computerworld’s Honors Program Laureate award, Computerworld’s “Top Five” recognition, a three-time awardee of CIO Magazine’s CIO 100 award, Computerworld’s Premier 100 IT leaders, Becker’s 100 CIOs to know and a Center for Medicare and Medicaid Innovation Award. He has also been nominated by the HealthTech Research Alliance & Council as Healthcare Innovator of the Year. Randy holds degrees from Temple University and Dartmouth College.

Stephen M. Goodman

Stephen M. Goodman is a partner in Morgan Lewis’s Business and Finance Practice and has been with the firm since 1994. His practice, focused on corporate finance and acquisitions, is dedicated to fostering emerging growth companies in the Philadelphia region through direct work with clients and active involvement in the emerging growth community.

As strategic counsel to startups in the technology and life sciences sectors, Steve identifies companies with potential and takes them from conception through product development, growth, and beyond. Some of the companies he has nurtured include CDnow, VerticalNet, ICG Commerce, AirClic, ExcelleRx, and AANet.com.

Steve is also founder of the firm’s “Connect at Morgan Lewis” program, which brings together investors and entrepreneurs and guides clients through the process of refining their investor presentations through individual coaching sessions. He is the longest-tenured member of the advisory board for the University of Pennsylvania’s Wharton Entrepreneurial Program. He also teaches “Legal Aspects of Entrepreneurship” at the University of Pennsylvania’s School of Law. In addition to his close involvement with clients and his support and participation in the regional entrepreneurial and venture capital networks, Steve devotes significant time to mentoring young lawyers in the firm.

Steve is a founder of and senior partner in the firm’s Emerging Business and Technology Practice. He has been consistently recognized by Chambers USA, an annual independent ranking of top lawyers, as an influential authority for his work with emerging growth companies. In May 2011, he received the Legend Award for Lifetime Achievement from the Greater Philadelphia Alliance for Capital and Technologies (PACT). In selecting Steve for the honor, PACT noted, “He has played a leading role in nurturing scores of prominent success stories and is considered a valuable asset to the Greater Philadelphia business community.”

Kevin Rakin

Kevin Rakin is a founding Partner at HighCape Partners, a growth equity life sciences investment firm. He was previously the President of Regenerative Medicine at Shire plc. Prior to joining Shire, Kevin served as the Chairman and CEO of Advanced BioHealing from 2007 until its acquisition by Shire, in June 2011.

Before this, he served as an executive-in-residence at Canaan Partners. Previously, he was a co-Founder, President & Chief Executive Officer of Genaissance Pharmaceuticals, Inc., a publicly held pharmacogenomics company, until its merger with Clinical Data, Inc. in October 2005.

Kevin currently serves as a Board member of CyVek, Inc, Cheetah Medical Inc., Histogenics Corp. and TELA Bio, Inc., and on the executive committee for CURE, Connecticut’s bioscience cluster. He has previously served as a Board member for Ipsogen SA, Vion Pharmaceuticals, Inc., OMRIX Biopharmaceuticals, Inc, and Clinical Data, Inc. Kevin received an M.B.A. from Columbia University and Graduate and undergraduate degrees from the University of Cape Town, South Africa.

Arthur H. Rubenstein, MBBCh

Arthur H. Rubenstein, MBBCh is a Professor in the Department of Medicine, Division of Endochrinology at Raymond & Ruth Perelman School of Medicine of Medicine at the University of Pennsylvania.

Previously, Arthur was Executive Vice President of the University of Pennsylvania for the Health System and Dean of the University of Pennsylvania School of Medicine. Before joining Penn, Arthur served for four years as Dean of Mount Sinai School of Medicine and Gustave L. Levy Distinguished Professor. Earlier, he was the Lowell T. Coggeshall Distinguished Service Professor of Medical Sciences and Chairman of the Department of Medicine at the University of Chicago Pritzker School of Medicine.

Arthur is an internationally prominent endocrinologist recognized for clinical expertise and groundbreaking research in diabetes. Well known for his inspired teaching, Arthur has served in numerous professional leadership positions during his career. These include President of the Association of Professors of Medicine, of the Association of American Physicians, and of the Central Society for Clinical Research; and Chairman of both the American Board of Internal Medicine and the National Diabetes Advisory Board. He has been a member of a study section and of the Advisory Council of the National Institute of Diabetes and Digestive and Kidney Diseases.

Author of more than 350 publications, Arthur has held editorial advisory positions with several respected journals, including service on the editorial boards of the Annals of Internal Medicine, the Journal of Diabetes and Its Complications, Medicine, and Clinical Trials Advisor. He was also a consulting editor to the Journal of Clinical Investigation.

Arthur is the recipient of many awards and prizes, including the highest honor from the Association of Professors of Medicine, the Robert H. Williams Distinguished Chair of Medicine Award. Among his other honors are the John Phillips Memorial Award from the American College of Physicians; the Banting Medal from the American Diabetes Association; and the David Rumbough Scientific Award from the Juvenile Diabetes Association.

Born in South Africa, Arthur received his medical degree from the University of the Witwatersrand in Johannesburg. In 2001, he was honored by his alma mater when an honorary degree, Doctor of Science in Medicine, was conferred upon him. He is a Fellow of the College of Medicine of South Africa and of the Royal College of Physicians of London; a Master of the American College of Physicians; and a member of the Institute of Medicine of the National Academy of Sciences.

Christopher Simon

Christopher Simon

For nearly 20 years, Christopher Simon has worked with clients in healthcare and consumer goods. He is a leader of McKinsey & Company’s Pharmaceutical and Medical Products Practice in North America and leads its work on medical products globally.

Mr. Simon’s work has included planning and executing company-wide performance turnaround of a leading medical device company and guiding sales and marketing transformations for a number of clients. Among his recent work, Mr. Simon led a number of domestic and global projects for leading medical device manufacturers, including the development of a corporate strategy for a novel CNS diagnostics company, and the redesign of development capabilities for a diversified med tech manufacturer with the aim of reducing time to market, improving regulatory affairs and accelerating product launch.

Healthcare is a return to Chris’ roots. Before joining McKinsey, he worked in the industry as a Regional Operations Manager and Account Executive for Baxter Healthcare. Prior to Baxter, Chris served as a U.S. Army Infantry Officer in Korea and with the 1st Ranger Battalion. He holds a Bachelor of Science degree in Economics from the University of Pennsylvania and an MBA from Harvard Business School.

Daniel M. Skovronsky, MD, PhD

Daniel M. Skovronsky is Founder, President and CEO of Avid Radiopharmaceuticals (a former Safeguard Partner Company), which was acquired by Eli Lilly in December 2010 for an upfront payment of $300 million, and the potential for an additional $500 million in additional payments contingent upon potential future regulatory and commercial milestones for Amyvid.

Dan has more than 20 peer-reviewed publications and two NIH-funded grants on Alzheimer’s disease research. Prior to establishing Avid, Dan served as Scientific Director of High Throughput Screening and Drug Discovery at the Center for Neurodegenerative Disease Research at the University of Pennsylvania. Dan trained as a resident in Pathology and completed a fellowship in Neuropathology at the Hospital of the University of Pennsylvania.

Dan received his MD and PhD from the University of Pennsylvania and did his undergraduate training in molecular biochemistry at Yale University. Dan is the recipient of numerous scientific and business awards and was recently named by the Philadelphia Business Journal as one of their “Forty under Forty” business leaders in the region. Dan recently received the Ernst & Young Entrepreneur Of The Year®; 2009 Award in the Emerging Company category in Greater Philadelphia, which recognizes outstanding entrepreneurs who are building and leading dynamic, growing businesses.

Scott A. Snyder, PhD

Scott Snyder is the President and Chief Strategy Officer of Mobiquity, a leader in delivering innovative wireless solutions for enterprises. He has over 25 years of experience in business leadership, strategic planning, and technology management for both Fortune 500 companies and start-up ventures.

Dr. Snyder has held executive positions with several Fortune 500 companies including GE, Martin Marietta, and Lockheed Martin, has been the CEO of a leading strategic planning firm, Decision Strategies International, and has also started business ventures in software including OmniChoice, a CRM/Analytics applications provider and Strategic Radar, a software-based solutions company focused on monitoring changes in the strategic environment.

Scott’s academic credentials include being a senior fellow in the Wharton School’s management department, an adjunct faculty member in the School of Engineering and Applied Science at the University of Pennsylvania and lecturing at MIT, RIT and CEDEP at INSEAD. He founded and leads the Wireless Innovation Council. He also sits on the advisory boards of Safeguard Scientifics, Fairmount Partners and several emerging-growth companies.

Dr. Snyder is the author of the popular book, “The New World of Wireless: How to Compete in the 4G Revolution”, released on Wharton Publishing in July 2009. He is a chapter author in the books “The Network Challenge: Strategy, Profit, and Risk in the Interlinked World” (Wharton Publishing, 2009) and “Inside the Minds: Small Business Growth Strategies: Goals for Successful CEOs” (Apatore Books, December 2007) and contributed as a co-author to several future scenario studies including “The Future of BioSciences 2020″ and “The Future of the US Energy Grid 2025″ from DSI. He has also authored several recent articles on wireless innovation including “Unwiring the Enterprise: Are You Ready to Lose Control?” in Knowledge@Wharton and “An Adoption Model for Consumer Wireless Sensor Initiatives” in the IEEE Consumer Electronics Journal.

Dr. Snyder is a Senior Fellow in the Management Department at the Wharton School, an Adjunct Faculty Member in the School of Engineering and Applied Science at the University of Pennsylvania, and has lectured at MIT, Babson, Duke, Insead, and RIT on Decision-making, Business and IT Strategy, Telecommunications, Product Design and Development, and Business Intelligence. He founded and leads the Wireless Innovation Council made up of leading companies focused on cross-sector mobile innovation opportunities. He also sits on the Advisory Boards of Safeguard Scientific and several emerging growth companies. He holds two patents for on-line decision aids and has been quoted as a thought leader in numerous publications including Forbes, Fox News, CNN, LA Times, Wall Street Journal, Tech Crunch, Philadelphia Inquirer, CIO Magazine, and Philadelphia Business Journal. Dr. Snyder earned his BS, MS, and Ph.D. in Systems Engineering from University of Pennsylvania and has an executive degree from USC in Telecommunications Management.

Chris Terrill

Chris Terrill is CEO of HomeAdvisor, a leading website offering comprehensive tools and resources for home improvement, maintenance and repair projects. Chris is a seasoned Internet veteran and has specialized in online subscription continuity business models, working for top tier brands such as Nutrisystem.com and Blockbuster.com.

Additionally, he spent six years with Match.com, most recently as Vice President of New Brands & Verticals. In this position, Chris launched new online brands, including Chemistry.com. He also serves on the Board of Neatco, the leading manufacturer of “digital filing cabinet” equipment and software storage.

Lee Yohannan

Lee Yohannan

Lee Yohannan is an accomplished business, technology and community leader who is inspired by the entrepreneurial spirit, an energized core of associates and integrity as the foundation for growth stage companies success and evolution.

As the Founding Partner of Liquidhub, Lee draws on more than 25 years as a Community leader, CEO, Partner, Investor and mentor of growth stage companies. Liquidhub is a digital integrator that partners with businesses to improve customer engagement and drive growth. With operations in North America, Asia and Europe Liquidhub empowers the leading global healthcare and financial services companies through technology innovation. Mr. Yohannan is also the Partner and Executive Chairman of Paycommerce, Inc where he is responsible for Corporate vision, Capital structure and Governance direction. Paycommerce is a leading next generation cloud-based global payment platform. Paycommerce integrated solutions support multiple payment types and settlements across the globe. Mr. Yohannan was named the regional Ernst & Young Entrepreneur of the Year in 2006 and was a national finalist in 2007.